What is she best known for?
The fields of study she is best known for:
- Internal medicine
- Gene
- Inflammation
Maria C. Cid mainly focuses on Internal medicine, Giant cell arteritis, Vasculitis, Surgery and Rheumatism.
Her research ties Endocrinology and Internal medicine together.
Her Giant cell arteritis study combines topics from a wide range of disciplines, such as Clinical trial, Arteritis, Tocilizumab, Radiology and Placebo-controlled study.
Her study brings together the fields of Immunology and Vasculitis.
Maria C. Cid interconnects Gastroenterology, Placebo, Immunopathology and Plasmacytoma, Multiple myeloma in the investigation of issues within Surgery.
Her studies deal with areas such as Polymyalgia rheumatica, Physical therapy and Evidence-based medicine as well as Rheumatism.
Her most cited work include:
- 2012 Revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides (2901 citations)
- EULAR Recommendations for the management of primary small and medium vessel vasculitis (717 citations)
- EULAR/ERA-EDTA recommendations for the management of ANCA-associated vasculitis. (473 citations)
What are the main themes of her work throughout her whole career to date?
Her primary scientific interests are in Giant cell arteritis, Internal medicine, Pathology, Vasculitis and Immunology.
Her Giant cell arteritis research is multidisciplinary, incorporating perspectives in Tocilizumab, Radiology and Arteritis.
Her research in Internal medicine intersects with topics in Gastroenterology, Endocrinology and Surgery.
As a part of the same scientific study, Maria C. Cid usually deals with the Pathology, concentrating on Inflammation and frequently concerns with Angiogenesis.
Her Vasculitis study frequently links to other fields, such as Vascular disease.
Her Prednisone study combines topics from a wide range of disciplines, such as Erythrocyte sedimentation rate, Placebo and Randomized controlled trial.
She most often published in these fields:
- Giant cell arteritis (41.80%)
- Internal medicine (33.20%)
- Pathology (27.34%)
What were the highlights of her more recent work (between 2016-2021)?
- Giant cell arteritis (41.80%)
- Internal medicine (33.20%)
- Tocilizumab (8.98%)
In recent papers she was focusing on the following fields of study:
Maria C. Cid spends much of her time researching Giant cell arteritis, Internal medicine, Tocilizumab, Gastroenterology and Prednisone.
Her Giant cell arteritis study which covers Guideline that intersects with Rheumatology.
Her work on Disease, Vasculitis and Glucocorticoid as part of general Internal medicine study is frequently linked to In patient, bridging the gap between disciplines.
Her Vasculitis study combines topics in areas such as Genome-wide association study and Angiography.
Her research on Tocilizumab also deals with topics like
- Systematic review which intersects with area such as Evidence-based medicine and Intensive care medicine,
- Clinical trial that intertwine with fields like Rheumatism.
The study incorporates disciplines such as Erythrocyte sedimentation rate, Placebo and Randomized controlled trial in addition to Prednisone.
Between 2016 and 2021, her most popular works were:
- Trial of Tocilizumab in Giant-Cell Arteritis. (455 citations)
- Mepolizumab or Placebo for Eosinophilic Granulomatosis with Polyangiitis (306 citations)
- 2018 Update of the EULAR recommendations for the management of large vessel vasculitis. (161 citations)
In her most recent research, the most cited papers focused on:
- Internal medicine
- Gene
- Inflammation
Maria C. Cid mainly focuses on Giant cell arteritis, Internal medicine, Tocilizumab, Vasculitis and Immunology.
Her Giant cell arteritis research is multidisciplinary, incorporating perspectives in Arteritis and Placebo-controlled study.
Her studies deal with areas such as Gastroenterology and Placebo as well as Internal medicine.
While the research belongs to areas of Tocilizumab, Maria C. Cid spends her time largely on the problem of Intensive care medicine, intersecting her research to questions surrounding Systemic vasculitis, Evidence-based medicine and Adverse effect.
Maria C. Cid has included themes like Imputation, Genome-wide association study and Allele in her Vasculitis study.
Her Immunology research incorporates elements of Myofibroblast and Endothelin 1.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
